Search bioRxiv⌕ Search

Biology subjects

Schirmbeck, G.

Publications and source records attributed to Schirmbeck, G..

2 recordsLinked to original sources

Minute- and second-scale hippocampal network dysfunctions in the 3xTgAD mouse model of Alzheimer's disease are prevented by TSPO knockout

The 18kDa translocator protein (TSPO) is widely recognized as a biomarker of neuroinflammation, but recent evidence suggests that it may also play a direct role in the pathophysiology of neurological conditions with an inflammatory component such as Alzheimers disease (AD). In this study, we leveraged functional ultrasound imaging (fUSi) to assess how TSPO knockout influences brain activity and connectivity in the 3xTgAD mouse model of AD. Resting-state scans were performed in 16-month-old male and female mice across four genotypes: WT, TSPO-/-, 3xTgAD or 3xTgAD.TSPO-/-. Using a data-driven approach, we identified key functional networks, including a bilateral hippocampal-amygdala limbic network. Dual regression analysis revealed increased engagement of the ventral hippocampus within the limbic network and elevated hemodynamic variance in 3xTgAD mice compared to WT. Moreover, co-activation patterns (CAPs) analysis showed abnormal activation/deactivation cycles involving the dorsal hippocampus, both of which were prevented by TSPO knockout without affecting amyloid or tau burden. Our findings highlight a functional role for TSPO in shaping network dynamics and suggest that its deletion can mitigate brain dysfunction in AD models.

neuroscience↗

Oxytocin release modulates acute neuroinflammation and improves brain development after pediatric traumatic brain injury

Pediatric traumatic brain injury (TBI) is a leading cause of death and disability early in life in infants, and its neurodevelopmental consequences cannot currently be effectively treated. Since TBI is associated with neuroinflammation, modulation of the post-injury neuroinflammatory response is a promising strategy. Oxytocin is thought to have anti-inflammatory properties and appears to play a role in clinical interventions that improve brain development in neonates. However, the underlying mechanisms remain unclear, as does its applicability to acute brain injury. Here we investigate the effects of chemogenetic modulation of endogenous oxytocin on acute neuroinflammation and on long-term brain development after TBI in postnatal day 7 (P7) male mice. We show that oxytocin release attenuates the acute neuroinflammatory response to TBI 24 hours after injury, by reducing the expression of immune- and inflammation-related genes in astrocytes and promoting gene pathways for brain repair and development in microglia. In the long term, oxytocin exposure ameliorates subcortical and cortical white matter damage after TBI, prevents hyperactivity and loss of social behavior, and restores TBI-induced alterations in resting-state functional connectivity of the isocortex. These findings enhance our understanding of the modulation of neuroinflammation and its long-term effects and support intervention related to endogenous oxytocin release as a promising neuroprotective strategy in pediatric TBI.

neuroscience↗